Quarterly Result23 May 2026, 04:41 pm
Sai Parenterals: Audited Results for FY26 Approved
AI Summary
Sai Parenterals Ltd. approved the audited financial results (standalone and consolidated) for the quarter and year ended March 31, 2026, along with the unaudited financial results for the quarter and nine months ended December 31, 2025. The board meeting, held on May 23, 2026, also approved the limited review report and auditors' report with an unmodified opinion. The meeting concluded at 4:15 p.m.
Key Highlights
- Audited FY26 financial results (standalone and consolidated) approved.
- Unaudited results for Q3 and nine months ended Dec 31, 2025, approved.
- Auditors' report with unmodified opinion for FY26 approved.
- Board meeting held on May 23, 2026, concluded at 4:15 p.m.
- Anil Kumar Karusala, Managing Director, declared unmodified audit opinion.
Price Impact
More from SAIPARENT